drugset / Trial / NCT00398281

Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer

NCT00398281 ↗

RandomizedDouble-blindDiagnostic

Summary

RATIONALE: Diagnostic procedures, such as ultrasound-guided biopsy, may help find prostate cancer. Dutasteride may improve the ability of ultrasound-guided biopsy to find prostate cancer. It is not yet known whether dutasteride followed by ultrasound-guided biopsy is more effective than a placebo followed by ultrasound-guided biopsy in finding prostate cancer. PURPOSE: This randomized phase III trial is studying dutasteride and ultrasound-guided biopsy to see how well they find prostate cancer compared with a placebo and ultrasound-guided biopsy.

Timeline

Start
2006-11
Primary completion
2010-07
Completion
2012-09

Outcome

Missed primary endpoint

paper Pretreatment with dutasteride had no significant impact on the detection of prostate cancer (p = 0.97). PMID 22998915 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dutasteride Small molecule — Oral

Indications